loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2006_029___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    FARMAK, a.s

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Farmak A.S. Olomouc CZ (1)

    filter

    01 Zopiclone (1)

    filter

    01 Czech Republic (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Farmak A.S. Olomouc CZ

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual BoothFarmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
    Contact Supplier Contact Supplier
    Flag Czech Republic
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zopiclone

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2006-029 - Rev 03
    Valid
    Chemical
    2022-06-10
    1060
    Farmak Company Banner

    CPhI South East Asia

    Attending

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-029 - Rev 03 of Farmak A.s. Olomouc Cz

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-029 - Rev 03 of Farmak A.s. Olomouc Cz 1

    20

    Farmak A.s. Olomouc Cz, based in Czech Republic, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    One of their significant offerings is Zopiclone, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-029 - Rev 03

    This Chemical Type CEP, issued on June 10, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1060 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY